O	0	7	Effects
O	8	10	of
O	11	21	prescribed
B-intervention	22	29	aerobic
I-intervention	30	38	exercise
O	39	45	volume
O	46	48	on
O	49	57	physical
O	58	66	activity
O	67	70	and
O	71	80	sedentary
O	81	85	time
O	86	88	in
O	89	103	postmenopausal
O	104	109	women
O	109	110	:
O	111	112	a
O	113	123	randomized
O	124	134	controlled
O	135	140	trial
O	140	141	.

O	142	150	Physical
O	151	159	activity
O	160	163	has
O	164	171	emerged
O	172	174	as
O	175	177	an
O	178	187	important
O	188	197	lifestyle
O	198	204	factor
O	205	208	for
O	209	216	primary
O	217	227	prevention
O	228	230	of
O	231	239	numerous
O	240	248	diseases
O	248	249	,
O	250	259	including
O	260	274	postmenopausal
O	275	281	breast
O	282	288	cancer
O	288	289	.

O	290	292	No
O	293	298	study
O	299	301	to
O	302	306	date
O	307	310	has
O	311	319	assessed
O	320	323	the
O	324	329	acute
O	330	333	and
O	334	338	long
O	338	339	-
O	339	343	term
O	344	351	effects
O	352	354	of
O	355	359	year
O	359	360	-
O	360	364	long
O	365	372	aerobic
O	373	381	exercise
O	382	390	programs
O	391	400	differing
O	401	403	in
O	404	414	prescribed
O	415	423	exercise
O	424	430	volume
O	431	433	on
O	434	442	physical
O	443	451	activity
O	452	455	and
O	456	465	sedentary
O	466	470	time
O	471	473	in
O	474	488	postmenopausal
O	489	494	women
O	494	495	.

O	496	505	Therefore
O	505	506	,
O	507	509	we
O	510	515	aimed
O	516	518	to
O	519	526	examine
O	527	530	the
O	531	538	effects
O	539	541	of
O	542	545	two
O	546	554	moderate
O	554	555	-
O	555	563	vigorous
O	564	573	intensity
O	574	582	exercise
O	583	588	doses
O	589	591	on
O	592	597	total
O	597	598	,
O	599	604	light
O	605	608	and
O	609	617	moderate
O	617	618	-
O	618	626	vigorous
O	627	636	intensity
O	637	645	physical
O	646	654	activity
O	655	660	times
O	660	661	,
O	662	665	and
O	666	675	sedentary
O	676	680	time
O	681	683	in
O	684	698	postmenopausal
O	699	704	women
O	705	711	during
O	712	715	the
O	716	720	year
O	720	721	-
O	721	725	long
O	726	738	intervention
O	739	742	and
O	743	746	one
O	747	751	year
O	752	757	later
O	757	758	.

O	759	762	The
O	763	769	Breast
O	770	776	Cancer
O	777	780	and
O	781	789	Exercise
O	790	795	Trial
O	796	798	in
O	799	806	Alberta
O	807	808	(
O	808	812	BETA
O	812	813	)
O	814	817	was
O	818	819	a
O	820	823	two
O	823	824	-
O	824	830	center
O	830	831	,
O	832	835	two
O	835	836	-
O	836	839	arm
O	839	840	,
O	841	843	12
O	843	844	-
O	844	849	month
O	850	860	randomized
O	861	871	controlled
O	872	877	trial
O	878	882	that
O	883	891	included
B-total-participants	892	895	400
B-eligibility	896	906	previously
I-eligibility	907	915	inactive
I-eligibility	916	930	postmenopausal
I-eligibility	931	936	women
O	937	947	randomized
O	948	950	to
O	951	957	either
O	958	961	150
O	962	963	(
O	963	971	MODERATE
O	971	972	)
O	973	975	or
O	976	979	300
O	980	981	(
O	981	985	HIGH
O	985	986	)
O	987	994	minutes
O	994	995	/
O	995	999	week
O	1000	1002	of
O	1003	1010	aerobic
O	1011	1019	exercise
O	1019	1020	.

O	1021	1029	Physical
O	1030	1038	activity
O	1039	1042	and
O	1043	1052	sedentary
O	1053	1057	time
O	1058	1062	were
O	1063	1071	assessed
O	1072	1074	at
O	1075	1083	baseline
O	1083	1084	,
O	1085	1086	6
O	1086	1087	-
O	1088	1089	(
O	1089	1101	intervention
O	1102	1105	mid
O	1105	1106	-
O	1106	1111	point
O	1111	1112	)
O	1112	1113	,
O	1114	1116	12
O	1116	1117	-
O	1118	1119	(
O	1119	1124	prior
O	1125	1127	to
O	1128	1131	end
O	1132	1134	of
O	1135	1147	intervention
O	1147	1148	)
O	1149	1152	and
O	1153	1155	24
O	1155	1156	-
O	1156	1162	months
O	1163	1164	(
O	1164	1170	follow
O	1170	1171	-
O	1171	1173	up
O	1173	1174	)
O	1175	1179	with
O	1180	1185	waist
O	1185	1186	-
O	1186	1193	mounted
O	1194	1208	accelerometers
O	1209	1210	(
O	1210	1219	Actigraph
O	1220	1224	GTX3
O	1224	1225	Â
O	1225	1226	®
O	1226	1227	)
O	1227	1228	.

O	1229	1233	Self
O	1233	1234	-
O	1234	1242	reported
O	1243	1251	activity
O	1252	1255	and
O	1256	1265	sedentary
O	1266	1270	time
O	1271	1273	at
O	1274	1282	baseline
O	1282	1283	,
O	1284	1286	12
O	1286	1287	-
O	1288	1291	and
O	1292	1294	24
O	1294	1295	-
O	1295	1301	months
O	1302	1305	was
O	1306	1310	also
O	1311	1319	assessed
O	1320	1321	(
O	1321	1325	Past
O	1326	1330	Year
O	1331	1336	Total
O	1337	1345	Physical
O	1346	1354	Activity
O	1355	1368	Questionnaire
O	1369	1372	and
O	1373	1376	SIT
O	1376	1377	-
O	1377	1378	Q
O	1378	1379	)
O	1379	1380	.

O	1381	1390	Intention
O	1390	1391	-
O	1391	1393	to
O	1393	1394	-
O	1394	1399	treat
O	1400	1408	analyses
O	1409	1413	were
O	1414	1423	conducted
O	1424	1429	using
O	1430	1436	linear
O	1437	1442	mixed
O	1443	1449	models
O	1450	1453	and
O	1454	1462	adjusted
O	1463	1466	for
O	1467	1475	baseline
O	1476	1485	variables
O	1485	1486	.

O	1487	1491	Both
O	1492	1500	physical
O	1501	1509	activity
O	1510	1523	interventions
O	1524	1527	led
O	1528	1530	to
O	1531	1540	increases
O	1541	1543	in
O	1544	1553	objective
O	1554	1557	and
O	1558	1568	subjective
O	1569	1577	measures
O	1578	1580	of
B-outcome	1581	1586	total
I-outcome	1587	1590	and
I-outcome	1591	1599	moderate
I-outcome	1599	1600	-
I-outcome	1600	1608	vigorous
I-outcome	1609	1618	intensity
I-outcome	1618	1619	/
I-outcome	1619	1631	recreational
I-outcome	1632	1640	physical
I-outcome	1641	1649	activity
I-outcome	1650	1654	time
O	1654	1655	,
O	1656	1663	coupled
O	1664	1668	with
O	1669	1678	decreases
O	1679	1681	in
B-outcome	1682	1691	sedentary
I-outcome	1692	1696	time
O	1696	1697	,
B-outcome	1698	1700	at
I-outcome	1701	1702	6
I-outcome	1702	1703	-
I-outcome	1704	1707	and
I-outcome	1708	1710	12
I-outcome	1710	1711	-
I-outcome	1711	1717	months
O	1718	1726	compared
O	1727	1729	to
O	1730	1738	baseline
O	1738	1739	.

O	1740	1752	Additionally
O	1752	1753	,
O	1754	1761	greater
O	1762	1771	increases
O	1772	1774	in
B-outcome	1775	1788	accelerometry
I-outcome	1788	1789	-
I-outcome	1789	1796	derived
I-outcome	1797	1802	total
I-outcome	1803	1811	physical
I-outcome	1812	1820	activity
I-outcome	1821	1825	time
I-outcome	1826	1828	at
I-outcome	1829	1830	6
I-outcome	1830	1831	-
I-outcome	1832	1835	and
I-outcome	1836	1838	12
I-outcome	1838	1839	-
I-outcome	1839	1845	months
O	1845	1846	,
O	1847	1850	and
B-outcome	1851	1855	self
I-outcome	1855	1856	-
I-outcome	1856	1864	reported
I-outcome	1865	1877	recreational
I-outcome	1878	1886	activity
I-outcome	1887	1891	time
I-outcome	1892	1894	at
I-outcome	1895	1897	12
I-outcome	1897	1898	-
I-outcome	1898	1904	months
O	1904	1905	,
O	1906	1914	compared
O	1915	1917	to
O	1918	1926	baseline
O	1927	1931	were
O	1932	1937	noted
O	1938	1940	in
O	1941	1944	the
O	1945	1949	HIGH
O	1950	1956	versus
O	1957	1965	MODERATE
O	1966	1972	groups
O	1972	1973	.

O	1974	1983	Decreases
O	1984	1986	in
B-outcome	1987	1992	total
I-outcome	1992	1993	,
I-outcome	1994	1999	light
I-outcome	2000	2003	and
I-outcome	2004	2012	moderate
I-outcome	2012	2013	-
I-outcome	2013	2021	vigorous
I-outcome	2022	2031	intensity
I-outcome	2032	2040	physical
I-outcome	2041	2049	activity
I-outcome	2050	2054	time
I-outcome	2054	2055	,
O	2056	2059	and
O	2060	2062	an
O	2063	2071	increase
O	2072	2074	in
B-outcome	2075	2084	sedentary
I-outcome	2085	2089	time
O	2089	2090	,
O	2091	2093	in
O	2094	2098	both
O	2099	2105	groups
O	2106	2110	were
O	2111	2116	noted
O	2117	2119	at
O	2120	2122	24
O	2122	2123	-
O	2123	2129	months
O	2130	2138	compared
O	2139	2141	to
O	2142	2144	12
O	2144	2145	-
O	2145	2151	months
O	2151	2152	.

O	2153	2154	A
O	2155	2163	decrease
O	2164	2166	in
B-outcome	2167	2172	light
I-outcome	2173	2182	intensity
I-outcome	2183	2191	physical
I-outcome	2192	2200	activity
I-outcome	2201	2205	time
O	2206	2208	in
O	2209	2213	both
O	2214	2220	groups
B-outcome	2221	2223	at
I-outcome	2224	2226	24
I-outcome	2226	2227	-
I-outcome	2227	2233	months
O	2234	2242	compared
O	2243	2245	to
O	2246	2254	baseline
O	2255	2258	was
O	2259	2263	also
O	2264	2269	noted
O	2269	2270	.

O	2271	2276	These
O	2277	2285	findings
O	2286	2290	have
O	2291	2300	important
O	2301	2307	health
O	2308	2320	implications
O	2320	2321	,
O	2322	2332	suggesting
O	2333	2337	that
O	2338	2343	total
O	2344	2352	physical
O	2353	2361	activity
O	2362	2366	time
O	2367	2370	can
O	2371	2373	be
O	2374	2383	increased
O	2384	2388	with
O	2389	2396	greater
O	2397	2404	volumes
O	2405	2407	of
O	2408	2418	prescribed
O	2419	2427	exercise
O	2427	2428	,
O	2429	2432	but
O	2433	2437	that
O	2438	2448	additional
O	2449	2456	support
O	2457	2460	and
O	2461	2470	resources
O	2471	2476	could
O	2477	2479	be
O	2480	2484	used
O	2485	2487	to
O	2488	2495	promote
O	2496	2499	the
O	2500	2511	maintenance
O	2512	2514	of
O	2515	2520	these
O	2521	2525	high
O	2526	2532	levels
O	2533	2535	of
O	2536	2543	aerobic
O	2544	2552	exercise
O	2553	2566	participation
O	2567	2576	following
O	2577	2582	study
O	2583	2593	completion
O	2593	2594	.
O	2595	2609	clinicaltrials
O	2609	2610	.
O	2610	2613	gov
O	2614	2624	identifier
O	2624	2625	:
O	2626	2637	NCT01435005
O	2638	2639	(
O	2639	2643	BETA
O	2644	2649	Trial
O	2649	2650	)
O	2650	2651	.

O	2652	2661	Registred
O	2662	2671	September
O	2672	2676	15th
O	2677	2681	2011
O	2682	2683	(
O	2683	2698	retrospectively
O	2699	2709	registered
O	2709	2710	)
O	2710	2711	.
